Search by Drug Name or NDC
NDC 00409-4346-73 Aminocaproic Acid 250 mg/mL Details
Aminocaproic Acid 250 mg/mL
Aminocaproic Acid is a INTRAVENOUS INJECTION, SOLUTION in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Hospira, Inc.. The primary component is AMINOCAPROIC ACID.
MedlinePlus Drug Summary
Aminocaproic acid injection is used to control bleeding that occurs when blood clots are broken down too quickly. This type of bleeding may occur during or after heart or liver surgery; in people who have certain bleeding disorders; in people who have cancer of the prostate (a male reproductive gland), lung, stomach, or cervix (opening of the uterus); and in pregnant women experiencing placental abruption (placenta separates from the uterus before the baby is ready to be born). Aminocaproic acid injection is also used to control bleeding in the urinary tract (the organs in the body that produce and excrete urine) that may occur after prostate or kidney surgery or in people who have certain types of cancer. Aminocaproic acid injection should not be used to treat bleeding that is not caused by faster than normal clot breakdown, so your doctor may order tests to find the cause of your bleeding before you begin your treatment. Aminocaproic acid injection is in a class of medications called hemostatics.
Related Packages: 00409-4346-73Last Updated: 11/30/2022
MedLinePlus Full Drug Details: Aminocaproic Acid Injection
Product Information
| NDC | 00409-4346 |
|---|---|
| Product ID | 0409-4346_549114bf-19dc-4781-a7f0-190c775d5817 |
| Associated GPIs | 84100010002005 |
| GCN Sequence Number | 006502 |
| GCN Sequence Number Description | aminocaproic acid VIAL 250 MG/ML INTRAVEN |
| HIC3 | M9D |
| HIC3 Description | ANTIFIBRINOLYTIC AGENTS |
| GCN | 25570 |
| HICL Sequence Number | 002801 |
| HICL Sequence Number Description | AMINOCAPROIC ACID |
| Brand/Generic | Generic |
| Proprietary Name | Aminocaproic Acid |
| Proprietary Name Suffix | n/a |
| Non-Proprietary Name | AMINOCAPROIC ACID |
| Product Type | HUMAN PRESCRIPTION DRUG |
| Dosage Form | INJECTION, SOLUTION |
| Route | INTRAVENOUS |
| Active Ingredient Strength | 250 |
| Active Ingredient Units | mg/mL |
| Substance Name | AMINOCAPROIC ACID |
| Labeler Name | Hospira, Inc. |
| Pharmaceutical Class | Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE] |
| DEA Schedule | n/a |
| Marketing Category | ANDA |
| Application Number | ANDA070010 |
| Listing Certified Through | 2024-12-31 |
Package
NDC 00409-4346-73 (00409434673)
| NDC Package Code | 0409-4346-73 |
|---|---|
| Billing NDC | 00409434673 |
| Package | 25 VIAL, SINGLE-DOSE in 1 TRAY (0409-4346-73) / 20 mL in 1 VIAL, SINGLE-DOSE (0409-4346-16) |
| Marketing Start Date | 2010-05-12 |
| NDC Exclude Flag | N |
| Pricing Information | N/A |